In our study, DPR attenuates obesity‐induced cardiac remodeling during aging, as evidenced by the normalization of heart weight and the suppression of hypertrophic markers, including Cyclin D1, NPPA, and DDB1. Here, DDB1 is linked to obesity disorder.